Amazon Basic Care Acetaminophen Tablets Recalled for Manufacturing Defects
Amazon Basic Care Acetaminophen tablets are being recalled due to manufacturing deviations that resulted in tablet discoloration. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall driven by manufacturing deviations (cGMP violations). However, no illnesses or injuries have been reported, and the hazard manifests only as observable discoloration rather than confirmed contamination or active harm.
Plain-English summary
Amazon Basic Care Acetaminophen tablets (325 mg, 100-count bottles) are being recalled due to manufacturing deviations that resulted in discoloration of the tablets. The product is manufactured by Aurobindo Pharma USA Inc and distributed by Amazon.com Services LLC.
The issue was identified through confirmed consumer complaints reporting brown discoloration on the tablets. This discoloration indicates deviations from current good manufacturing practices (cGMP).
The recall affects 4,608 bottles that were distributed nationwide in the United States. The affected lot is AEF124004A with an expiration date of August 31, 2026. Consumers who have purchased this product should stop use and consult their healthcare provider if they have concerns. To date, no illnesses or injuries related to this recall have been reported.
The recalled product
- Product
- AMAZON BASIC CARE ACETAMINOPHEN (ACETAMINOPHEN)
- Brand
- AMAZON BASIC CARE ACETAMINOPHEN
- Manufacturer
- Aurobindo Pharma USA Inc
- Category
- Drug
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: AEF124004A
- Exp date 08/31/2026
UPCs (1)
- 0195515048866
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27